Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch | Reuters
Teva down as it reports lower sales and profit for 2018
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva Pharmaceutical Industries Stock Is Believed To Be Modestly Undervalued
Teva Pharmaceutical pledges 'dignity and respect' in layoffs at Antioch and Gurnee distribution centers – Chicago Tribune
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Top Real Estate Deals 2018: Big suburban HQ leases - Kansas City Business Journal
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva to Launch New Growth Strategy at Investor Day
Teva Will Pay Up to $126 Million to U.S. Hospitals Over Opioids - news.law
Pharma giant seals the deal on massive N.J. office, will bring more than 800 jobs - nj.com
Teva Pharmaceuticals moving HQ from Montgomery County to New Jersey – thereporteronline
27 Teva Festival Styling Suite Stock Photos, High-Res Pictures, and Images - Getty Images
FDA rejects Perrigo knockoff of Teva's ProAir inhaler for third time | Fierce Pharma
Teva (TEVA) to Cut Back Generic Drug Production Amid Shortages - Bloomberg
Teva warns on 2018 profit, may face migraine drug delays | Reuters
FDA rejects Celltrion/Teva's rituximab and trastuzumab biosimilars
New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion | Business Wire
Daisy Ridley in Chloe at the "Star Wars" premiere - Chic Sandal Collection – Rvce News - Teva & brown chloe paddington leather handbag bag Partner on Rocker
Teva Hurricane XLT 2 – Sole Provisions
247 Pharmaceutical Industries Teva Photos & High Res Pictures - Getty Images
Teva Pharmaceuticals on X: "Teva's digital customer engagement director Jannick Larsen talks internal building blocks for social media @pharmaconf #pharmaconf in London today. https://t.co/4Q5LqL0yh4" / X
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7KA2RJPZ3ZLYLG75XTZPEVUG7Q.jpg "Teva drops migraine-drug patent case against Eli Lilly | Reuters")